Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
12-Jan-2026 | 1,063 | 1,065.4 | 1,019.1 | 1,050.5 | 15,355 | 12,60,26,222.3 | 50,786 |
13-Jan-2026 | 1,044 | 1,051 | 1,034.7 | 1,040.6 | 14,683 | 12,69,56,741.2 | 61,742 |
14-Jan-2026 | 1,031.1 | 1,073 | 1,031.1 | 1,066.3 | 13,143 | 10,42,66,932.1 | 47,493 |
16-Jan-2026 | 1,055.7 | 1,067.9 | 1,040 | 1,045.6 | 9,817 | 6,29,97,666.6 | 25,401 |
19-Jan-2026 | 1,031 | 1,032 | 983.6 | 994.5 | 20,291 | 20,76,45,696.8 | 92,623 |
20-Jan-2026 | 994 | 996 | 944.6 | 950.8 | 16,217 | 18,56,80,059.6 | 96,357 |
21-Jan-2026 | 942.2 | 961.7 | 932.6 | 946.8 | 27,964 | 34,47,44,924.7 | 2,17,311 |
22-Jan-2026 | 954.9 | 973.6 | 952.1 | 968 | 7,627 | 5,22,60,240.7 | 29,079 |
23-Jan-2026 | 968 | 969.5 | 926.9 | 956.1 | 12,942 | 13,29,19,023.3 | 76,812 |
27-Jan-2026 | 951 | 955.9 | 929.6 | 938.9 | 12,659 | 9,15,54,494.9 | 42,050 |
28-Jan-2026 | 940.9 | 970 | 937.4 | 962.2 | 13,098 | 7,69,65,967.3 | 42,552 |
29-Jan-2026 | 965 | 966.1 | 931 | 938.1 | 15,542 | 13,67,41,879.8 | 75,008 |
30-Jan-2026 | 942 | 991 | 930 | 981.9 | 17,196 | 15,21,01,212.3 | 75,204 |
01-Feb-2026 | 981.9 | 985.35 | 948.3 | 967.85 | 6,171 | 4,76,28,731.85 | 20,139 |
02-Feb-2026 | 959.1 | 969.05 | 930.15 | 957.75 | 10,429 | 8,64,37,737.4 | 41,656 |
03-Feb-2026 | 996 | 998.35 | 965.5 | 988.75 | 11,540 | 14,58,71,371.15 | 83,924 |
04-Feb-2026 | 981.5 | 991 | 965.6 | 969.85 | 8,483 | 6,48,36,513.65 | 32,571 |
05-Feb-2026 | 972.95 | 977.6 | 957.45 | 973.85 | 4,481 | 3,59,49,295.1 | 15,911 |
06-Feb-2026 | 973.85 | 976.4 | 929.6 | 937.65 | 32,521 | 36,90,77,803.4 | 74,240 |
The API division posted a turnover of ₹609 Crore for the financial year ended March 2025. This was 8.35% of the company’s consolidated revenue.
Here are some of the stocks that may see significant price movement today: Torrent Power, DCM Shriram, Jubilant Pharmova, etc.
This FDA audit confirms compliance with regulatory standards, enhancing the credibility of Jubilant's operations in the United States.
Jubilant Pharmova Ltd has gained a total of 126% in the last one year, and almost 75% gain since the beginning of the year.
Here are some of the stocks that may see significant price movement today: Tata Motors, Reliance Industries, IREDA, etc.
Drug company Jubilant Pharmova Ltd will acquire an 80% stake in Pierre Fabre Laboratories' Research & Development Centre in Saint Julien, France.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.